SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRoebuck Food Regulatory News (RFG)

Share Price Information for Roebuck Food (RFG)

Share Price is delayed by 15 minutes
Get Live Data
26.50    0.00 (0.00%)
Bid:
26.00
Ask:
27.00
Spread: 1.00 (3.846%)
Market Cap: £26.80m
RFG Live PriceLast checked at - London Stock Exchange

Intraday Roebuck Food Share Chart

Trading Update

27 Jan 2026 07:00

RNS Number : 4353Q
Roebuck Food Group PLC
27 January 2026
 

Trading Update

 

Roebuck Food Group plc (AIM:RFG) is pleased to provide the following Trading Update in respect of the year ended 31 December 2025.

 

GlasPort Bio, which was consolidated from 7 February 2025, has made significant progress and achieved many milestones towards commercialisation of GasAbate during the year;

· Built out a strong commercial team under the leadership of CEO, Justin McCarthy

· Completed pilot installations on large-scale commercial farms in three countries in conjunction with leading food processors. GlasPort Bio now has installations across specialist dairy, pig, and beef enterprises, with the GasAbate system installed on both indoor and outdoor storage facilities

· First recurring revenues generated by GlasPort Bio in Q4 FY25

· Best-in-class manure-methane abatement MRV (Measurement, Reporting, Verification) system designed and delivered

· Third-party Assurance attained from the Carbon Trust Assurance, confirming methane abatement by an average of 78%. Carbon Trust Assurance is the independent assurance arm of the leading global climate consultancy, the Carbon Trust which has 6 offices globally.

· Further non-dilutive grant funding of €1.85m secured (and a further €0.55m for Glasport RumenTech) 

 

Moorhead & McGavin (M&M) / Foro Food Solutions, our wholly-owned plant-based ingredients division which supplies Food Service and Food Manufacturing in the UK and Ireland had a difficult year in 2025. As outlined in our Interim Statement of 30 September 2025, the UK Food Service market was particularly difficult with M&M sales down by 23% at the half year, but showed signs of stabilisation in the second half. We are pleased to confirm that this improving trend continued to year-end.

· M&M sales grew by 2% in Q3 and 4% inQ4, leaving full-year sales down 11%; this comprised price deflation of -5.9%, volume -5.6%, and mix +0.5%

· Division sales including Foro were GBP 10.9m, -4.7% on FY24. 

· Division was EBITDA positive in FY25, albeit well down on FY24

· Action taken to manage costs and diversify suppliers and customers, positions the division for sales growth and profit recovery in 2026

· Significant new contract win with leading multinational food manufacturing group

· Management is looking at various options to optimise the value of our investment in this business

 

Central plc costs were significantly reduced in FY25 and will fall further in FY26.

 

Preliminary Results for the year ended 31 December 2025 will be published at the end of March 2025.

 

 

Enquiries:

Roebuck Food Group

Aidan Hughes, Finance Director

Telephone: + 44 28 3049 3399

 

Davy (Nomad)

Anthony Farrell

Telephone: + 353 1 679 6363

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTAKABPOBKDCDB
Date   Source Headline
2nd Jun 202611:10 amRNSShareholding Clarification
2nd Jun 20267:00 amRNSChange of Nominated Adviser
28th May 202611:32 amRNSResult of AGM
5th May 20263:35 pmRNSAnnual Report 2025 and Notice of AGM 2026
29th Apr 20262:44 pmRNSPreliminary Results
27th Jan 20267:00 amRNSTrading Update
30th Sep 202512:00 pmRNSInterim Results 2025
30th May 20255:30 pmRNSResult of AGM
2nd May 20259:00 amRNSAnnual Report 2024 and Notice of AGM 2025
28th Mar 20257:00 amRNSPreliminary Results
25th Feb 20252:00 pmRNSAppointment of Non-Executive Director and Chairman
7th Feb 20256:08 pmRNSCompletion of Investment
28th Jan 20255:45 pmRNSHolding(s) in Company
23rd Jan 20253:19 pmRNSResult of Extraordinary General Meeting
2nd Jan 20257:00 amRNSDate of Upcoming EGM
23rd Dec 20242:54 pmRNSPosting of Circular with Notice of EGM
20th Dec 20246:26 pmRNSResult of Placing and Subscription
20th Dec 202412:00 pmRNSProposed co-Investor and Fundraise Update
13th Dec 20246:14 pmRNSProposed Investment and Fundraising
22nd Nov 20247:00 amRNSNotification of substantial shareholding
21st Oct 20243:00 pmRNSChairman Ted O’Neill
27th Sep 20247:00 amRNSInterim Results 2024
6th Sep 20242:15 pmRNSDisposal of Animal Protein Division
29th Aug 20249:45 amRNSResult of Extraordinary General Meeting
9th Aug 20242:50 pmRNSPosting of Circular with Notice of EGM
1st Aug 20247:00 amRNSProposed disposal of Animal Protein Division
5th Jul 20245:10 pmRNSHolding(s) in Company
5th Jul 20245:00 pmRNSHolding(s) in Company
30th May 20243:30 pmRNSResult of AGM
29th May 20245:20 pmRNSDisposal of Dairy Division
14th May 20245:50 pmRNSNotice of AGM
30th Apr 20244:30 pmRNS2023 Annual Report
28th Mar 202410:20 amRNSCHAIRMAN'S STATEMENT - FINAL RESULTS
11th Jan 20244:50 pmRNSContinuance in Office of Director
4th Dec 20236:18 pmRNSIssue of Consideration Shares
30th Nov 20233:04 pmRNSResults of Extraordinary General Meeting
6th Nov 20235:10 pmRNSPlacing and Related Subscription Update
6th Nov 20232:00 pmRNSPosting of Circular with Notice of EGM
3rd Nov 20236:28 pmRNSResult of Placing and related Subscription
3rd Nov 20237:05 amRNSProposed Acquisition and Launch of Placing
29th Sep 20237:00 amRNSInterim results 2023
29th Sep 20237:00 amRNSResult of AGM
29th Aug 20234:28 pmRNSNotice of AGM
5th Jul 20237:00 amRNSManagement and Directorate Changes
28th Apr 20235:30 pmRNS2022 Annual Report
14th Apr 202310:00 amRNSDirectorate Change
31st Mar 20232:13 pmRNSChairman's Statement - Final Results
3rd Mar 20235:45 pmRNSExecutive Director Bonus
30th Dec 20227:00 amRNSDeputy Chairman
17th Nov 20225:00 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.